{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:05:17Z","timestamp":1792555517437,"version":"4.5.0"},"reference-count":34,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Among the forms of idiopathic hyperhidrosis, those involving the forehead have the greatest impact on patients\u2019 quality of life, as symptoms are not very controllable and are difficult to mask for patients. Although the local injection therapy with Incobotulinum toxin type A (IncoBTX-A therapy) can be considered a rational treatment, data from the literature describing both efficacy and safety of the treatment over the long term are poor. The aim of this report is to describe the single-center experience of five patients seeking treatment, for forehead hyperhidrosis with IncoBTX-A. To evaluate the benefits, safety profile and duration of anhidrosis, patients were treated following a standardized procedure and then followed until clinical relapse. The amount of sweating was measured by gravimetric testing, the extension of hyperhidrosis area was measured through Minor\u2019s iodine starch test, and response to the treatment was evaluated using the Hyperhidrosis Disease Severity Scale (HDSS) and the Dermatology Life Quality Index (DLQI). In all treated patients, a significant anhidrotic effect was observed 4 weeks after the treatment and lasted for approximately 36 weeks. The reduction in sweat production was associated with significant amelioration of symptoms and quality of life for all treated patients. No serious side effects occurred; one patient complained of a mild transient bilateral ptosis. Although further wider studies are required, our preliminary results seem to encourage the use of IncoBTX-A in forehead hyperhidrosis.<\/jats:p>","DOI":"10.3390\/toxins14060372","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T05:25:42Z","timestamp":1653974742000},"page":"372","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-0839","authenticated-orcid":false,"given":"Anna","family":"Campanati","sequence":"first","affiliation":[{"name":"Dermatological Clinic, Polytechnic Marche University, 60200 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Martina","sequence":"additional","affiliation":[{"name":"Dermatological Clinic, Polytechnic Marche University, 60200 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatis","family":"Gregoriou","sequence":"additional","affiliation":[{"name":"First Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, \u201cAndreas Sygros\u201d Hospital for Cutaneous and Venereal Diseases, 16121 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kontochristopoulos","sequence":"additional","affiliation":[{"name":"Departments of Dermatology-Venereology Andreas Sygros Hospital, 16121 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Paolinelli","sequence":"additional","affiliation":[{"name":"Dermatological Clinic, Polytechnic Marche University, 60200 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Diotallevi","sequence":"additional","affiliation":[{"name":"Dermatological Clinic, Polytechnic Marche University, 60200 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3153-1026","authenticated-orcid":false,"given":"Giulia","family":"Radi","sequence":"additional","affiliation":[{"name":"Dermatological Clinic, Polytechnic Marche University, 60200 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Bobyr","sequence":"additional","affiliation":[{"name":"Dermatological Clinic, Polytechnic Marche University, 60200 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Marconi","sequence":"additional","affiliation":[{"name":"Dermatological Clinic, Polytechnic Marche University, 60200 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1640-6609","authenticated-orcid":false,"given":"Giulio","family":"Gualdi","sequence":"additional","affiliation":[{"name":"Dermatologic Clinic, Department of Medicine, and Aging Science, University D\u2019Annunzio Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1589-9672","authenticated-orcid":false,"given":"Paolo","family":"Amerio","sequence":"additional","affiliation":[{"name":"Dermatologic Clinic, Department of Medicine, and Aging Science, University D\u2019Annunzio Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Offidani","sequence":"additional","affiliation":[{"name":"Dermatological Clinic, Polytechnic Marche University, 60200 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"ref_1","first-page":"523","article-title":"Management of Primary Focal Hyperhidrosis: An Algorithmic Approach","volume":"20","author":"Liu","year":"2021","journal-title":"J. Drugs Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.det.2014.06.001","article-title":"Botulinum Toxin for Hyperhidrosis of Areas Other than the Axillae and Palms\/Soles","volume":"32","author":"Glaser","year":"2014","journal-title":"Dermatol. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000452341","article-title":"Botulinum Toxin Off-Label Use in Dermatology: A Review","volume":"3","author":"Campanati","year":"2017","journal-title":"Ski. Appendage Disord."},{"key":"ref_4","first-page":"52","article-title":"Plantar focal idiopathic hyperhidrosis and botulinum toxin: A pilot study","volume":"17","author":"Campanati","year":"2007","journal-title":"Eur. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1468-1331.2011.03559.x","article-title":"Five-year experience with incobotulinumtoxinA (Xeomin\u00ae): The first botulinum toxin drug free of complexing proteins","volume":"19","author":"Dressler","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.36849\/JDD.2020.4989","article-title":"Randomized Controlled Trial Comparing the Efficacy and Safety of Two Injection Techniques of IncobotulinumtoxinA for Axillary Hyperhidrosis","volume":"19","author":"Noriega","year":"2020","journal-title":"J. Drugs Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00702-010-0372-0","article-title":"Comparing Botox\u00ae and Xeomin\u00ae for axillar hyperhidrosis","volume":"117","author":"Dressler","year":"2010","journal-title":"J. Neural Transm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2009.02877.x","article-title":"Routine use of Xeomin\u00ae in patients previously treated with Botox\u00ae: Long term results","volume":"16","author":"Dressler","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00702-013-1074-1","article-title":"Onabotulinumtoxin type A (Botox\u00ae) versus Incobotulinumtoxin type A (Xeomin\u00ae) in the treatment of focal idiopathic palmar hyperhidrosis: Results of a comparative double-blind clinical trial","volume":"121","author":"Campanati","year":"2013","journal-title":"J. Neural Transm. (Vienna)"},{"key":"ref_10","first-page":"1001","article-title":"Histological and Clinical Findings in Different Surgical Strategies for Focal Axillary Hyperhidrosis","volume":"34","author":"Bechara","year":"2008","journal-title":"Dermatol. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.burns.2013.03.002","article-title":"Topical ozonated oil versus hyaluronic gel for the treatment of partial- to full-thickness second-degree burns: A prospective, comparative, single-blind, non-randomised, controlled clinical trial","volume":"39","author":"Campanati","year":"2013","journal-title":"Burns"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1365-2133.2008.08476.x","article-title":"Topical glycopyrrolate for patients with facial hyperhidrosis","volume":"158","author":"Kim","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/imj.15489","article-title":"Retrospective analysis of the efficacy and duration of botulinum toxin A injections in 30 patients with palmar hyperhidrosis","volume":"51","author":"Farrell","year":"2021","journal-title":"Intern. Med. J."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Martina, E., Diotallevi, F., Radi, G., Campanati, A., and Offidani, A. (2021). Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review. Toxins, 13.","DOI":"10.3390\/toxins13020120"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jaad.2019.11.042","article-title":"Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis","volume":"82","author":"Nawrocki","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s11845-019-02131-3","article-title":"Five-year follow-up of patients treated with intra-dermal botulinum toxin for axillary hyperhidrosis","volume":"189","author":"Lynch","year":"2020","journal-title":"Ir. J. Med. Sci."},{"key":"ref_17","first-page":"1","article-title":"The Treatment of Primary Focal Hyperhidrosis","volume":"24","author":"Wechter","year":"2019","journal-title":"Skin Ther. Lett."},{"key":"ref_18","unstructured":"(2022, May 05). International Hyperhdrosis Society Official Website. Available online: https:\/\/www.sweathelp.org\/medical-professional-resources.html."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s004150070073","article-title":"Botulinum toxin for treatment of craniofacial hyperhidrosis","volume":"247","author":"Herath","year":"2000","journal-title":"J. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1365-2133.2000.03839.x","article-title":"Effective treatment of frontal hyperhidrosis with botulinum toxin A","volume":"143","author":"Kinkelin","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/bjd.12568","article-title":"Botulinum toxin for focal hyperhidrosis of the face","volume":"170","author":"George","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/ced.12362","article-title":"Comparison of efficacy and diffusion of three formulations of botulinum toxin type A in two patients with forehead hyperhidrosis","volume":"39","author":"Ko","year":"2014","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_23","first-page":"1651","article-title":"A Comparison of Two Botulinum Type A Toxin Preparations for the Treatment of Glabellar Lines: Double-Blind, Randomized, Pilot Study","volume":"31","author":"Lowe","year":"2005","journal-title":"Dermatol. Surg."},{"key":"ref_24","first-page":"A212","article-title":"Comparison of the therapeutic windows of different botulinum neurotoxin preparations in an animal model","volume":"60","author":"Aoki","year":"2003","journal-title":"Neurology"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ando, Y., Ohshima, Y., Yanagishita, T., Watanabe, H., Tamada, Y., Akiyama, M., and Watanabe, D. (2022). Clinical utility of botulinum toxin type A local injection therapy for head and forehead hyperhidrosis. J. Dermatol., Early View.","DOI":"10.1111\/1346-8138.16368"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1468-1331.2009.02879.x","article-title":"Xeomin\u00ae: An innovative new botulinum toxin type A","volume":"16","author":"Frevert","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.toxicon.2009.03.010","article-title":"Xeomin\u00ae is free from complexing proteins","volume":"54","author":"Frevert","year":"2009","journal-title":"Toxicon"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Samadzadeh, S., \u00dcrer, B., Brauns, R., Rosenthal, D., Lee, J.-I., Albrecht, P., and Hefter, H. (2020). Clinical Implications of Difference in Antigenicity of Different Botulinum Neurotoxin Type A Preparations: Clinical Take-Home Messages from Our Research Pool and Literature. Toxins, 12.","DOI":"10.3390\/toxins12080499"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.toxicon.2010.12.019","article-title":"Studies on the dissociation of botulinum neurotoxin type A complexes","volume":"57","author":"Eisele","year":"2010","journal-title":"Toxicon"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1468-3083.2010.03880.x","article-title":"Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: Clinical predictive factors of relapse-free survival","volume":"25","author":"Campanati","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00403-013-1380-3","article-title":"Treatment of palmar hyperhidrosis with botulinum toxin type A: Results of a pilot study based on a novel injective approach","volume":"305","author":"Campanati","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"ref_32","first-page":"908","article-title":"A Comprehensive Approach to the Recognition, Diagnosis, and Severity-Based Treatment of Focal Hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory Committee","volume":"33","author":"Solish","year":"2007","journal-title":"Dermatol. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1524-4725.2009.01364.x","article-title":"Recommendations for Performing and Evaluating the Results of the Minor Test According to a Sweating Intensity Visual Scale","volume":"36","author":"Hexsel","year":"2010","journal-title":"Dermatol. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology life quality index (DLQI)\u2014A simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin. Exp. Dermatol."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/14\/6\/372\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:19:39Z","timestamp":1760138379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/14\/6\/372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["toxins14060372"],"URL":"https:\/\/doi.org\/10.3390\/toxins14060372","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,27]]}}}